5th Annual General Shareholders' Meeting convened

2023-03-14

RudaCure

AI-driven ion channel drug discovery platform developing non-opioid therapeutics for pain and sensory diseases.

9 Songdo Mirae-ro, Yeonsu-gu, Incheon, Korea

Tel: 032-724-9070 | Fax: 032-724-9071

sh.kim@rudacure.com

Redefining Pain, Restoring Sensation